切换至 "中华医学电子期刊资源库"

中华临床医师杂志(电子版) ›› 2019, Vol. 13 ›› Issue (01) : 22 -26. doi: 10.3877/cma.j.issn.1674-0785.2019.01.005

所属专题: 文献

临床研究

PCI血运重建程度对多支病变冠心病患者平板运动试验的影响
王岚1, 郭丹杰2,(), 薛霖1, 牛亚芊芊1, 张天宏1, 郭琳1   
  1. 1. 100044 北京大学人民医院心血管内科 急性心肌梗死早期预警和干预北京市重点实验室 北京大学人民医院心血管转化医学研究中心
    2. 100044 北京大学人民医院科研处
  • 收稿日期:2018-10-10 出版日期:2019-01-01
  • 通信作者: 郭丹杰

Effect of complete or incomplete percutaneous coronary intervention revascularization on treadmill exercise testing in patients with multivessel coronary artery disease

Lan Wang1, Danjie Guo2,(), Lin Xue1, Yaqianqian Niu1, Tianhong Zhang1, Lin Guo1   

  1. 1. Department of Cardiology, Peking University People′s Hospital; Beijing Key Laboratory of Early Prediction and Intervention of Acute Myocardial Infarction; Center for Cardiovascular Translational Research, Peking University People′s Hospital, Beijing 100044, China
    2. Department of Research, Peking University People′s Hospital, Beijing 100044, China
  • Received:2018-10-10 Published:2019-01-01
  • Corresponding author: Danjie Guo
  • About author:
    Corresponding auther: Guo Danjie, Email:
引用本文:

王岚, 郭丹杰, 薛霖, 牛亚芊芊, 张天宏, 郭琳. PCI血运重建程度对多支病变冠心病患者平板运动试验的影响[J]. 中华临床医师杂志(电子版), 2019, 13(01): 22-26.

Lan Wang, Danjie Guo, Lin Xue, Yaqianqian Niu, Tianhong Zhang, Lin Guo. Effect of complete or incomplete percutaneous coronary intervention revascularization on treadmill exercise testing in patients with multivessel coronary artery disease[J]. Chinese Journal of Clinicians(Electronic Edition), 2019, 13(01): 22-26.

目的

从平板运动试验(TET)的角度,探讨不同经皮冠状动脉介入术(PCI)血运重建策略对于多支病变冠心病患者运动耐量及心肌缺血的影响。

方法

选取北京大学人民医院2014年8月至2016年6月经冠状动脉造影证实多支病变,行PCI并完成TET的116例冠心病患者,根据血运重建程度分为完全血运重建组(CR组,56例)及不完全血运重建组(ICR组,60例)。收集两组患者一般情况[年龄、性别、体质量指数(BMI)、吸烟情况]、合并疾病、服药情况、冠心病病史及病变情况、TET 1周内超声心动图所示射血分数以及TET结果等资料。对CR组和ICR组患者:对年龄,BMI,射血分数,TET中静息心率、静息收缩压、静息舒张压、峰值心率、峰值收缩压、峰值舒张压等数据采用独立样本t检验;对TET距离血运重建时间,血运重建前后Gensini评分,TET中Bruce分级、运动时间、最大代谢当量、ST段下降程度、ST段下降持续时间、最早出现ST段下降的Bruce分级、Duke评分等数据采用Mann-Whitney U检验;对患者中男性、吸烟者、合并疾病、用药情况、心肌梗死史、三支病变、左主干病变、前降支病变、回旋支病变、右冠状动脉病变、心肌桥等的分布情况,TET中ST段水平或下斜型下降≥0.1 mV、提前中止TET、ST段下降形态、胸痛、Duke评分分级等的分布情况采用χ2检验。

结果

CR组和ICR组两组患者一般临床情况(包括性别、年龄、BMI、吸烟情况、合并疾病、用药情况以及射血分数等)比较差异均无统计学意义(P均>0.05)。CR组与ICR组患者冠心病病史及冠状动脉病变情况:与CR组相比,ICR组患者三支病变比例、前降支病变比例、回旋支病变比例以及血运重建后Gensini评分均较高,差异具有统计学意义(51.8% vs 81.7%,χ2=11.741,P=0.001;90.2% vs 98.5%,χ2=4.436,P=0.035;78.6% vs 93.3%,χ2=5.308,P=0.021;[5(0,14)vs 23(12,36),Z=-5.268,P<0.001];其余资料(包括心肌梗死史比例、TET距离血运重建的时间、左主干病变比例、右冠状动脉病变比例、心肌桥比例及血运重建前Gensini评分)两组间差异无统计学意义(P均>0.05)。CR组及ICR组患者TET结果:两组患者均可达到Bruce 3(2,3)级,两组患者运动时间、TET阳性率、Duke评分以及TET其他各项参数差异均无统计学意义(P均>0.05)。

结论

在多支病变接受PCI的冠心病患者,ICR患者的运动耐量、心肌缺血情况及Duke评分等均不逊于CR患者。

Objective

To explore the effect of different percutaneous coronary intervention (PCI) revascularization strategies on exercise tolerance and myocardial ischemia in patients with coronary multivessel disease from the point of view of treadmill exercise testing (TET).

Methods

One hundred and sixteen coronary multivessel disease patients who underwent PCI revascularization and TET from August 2014 to June 2016 were studied. The patients were divided into either a complete revascularization group (CR group; n=56) or an incomplete revascularization group (ICR group; n=60). Clinical manifestations, combined diseases, medications, coronary heart disease status, ultracardiographic data, and TET data of these patients were collected and analyzed. The independent samples t-test was used to analyze the data of age, body mass index, ejection fraction, resting heart rate, resting systolic pressure, resting diastolic pressure, peak heart rate, peak systolic pressure, and peak diastolic pressure. The Mann-Whitney U-test was used to analyze the data of duration from revascularization to TET, Gensini score before and after revascularization, Bruce grade, exercise time, maximum metabolic equivalent, degree and duration of ST-segment depression, Bruce grade in the presence of ST-segment depression, and Duke score. The χ2 test was used to analyze the distribution of males, smokers, complications, medications, history of myocardial infarction, three-vessel lesions, left main lesion, anterior descending artery lesion, circumflex artery lesion, right coronary artery lesion, myocardial bridge, ST segment level or descending depression≥0.1 mV, early termination of TET, ST segment depression, chest pain, and Duke grade.

Results

The common clinical stootus between the CR group and ICR group had no significant difference (P>0.05). Compared with the CR group, the ICR group had significantly higher proportions of three-vessel lesion (51.8% vs 81.7%, χ2=11.741, P=0.001), anterior descending artery lesion (90.2% vs 98.5%, χ2=4.436, P=0.035), and left circumflex artery lesion (78.6% vs 93.3%, χ2=4.436, P=0.021) as well as higher Gensini score after revascularization [5 (0,14) vs 23 (12, 36), Z=-5.268, P<0.001]. The patients in both groups could reach Bruce 3 (2,3) level during TET. No significant difference was observed in the positive rate of TET, Duke score, or other TET data between the two groups.

Conclusion

For coronary multivessel disease patients after PCI, the TET results in patients undergoing incomplete revascularization are not inferior to those in patients undergoing complete revascularization.

表1 CR组和ICR组患者一般临床情况比较
表2 CR组和ICR组患者冠心病病史及冠状动脉病变情况比较
表3 CR组与ICR组患者TET结果比较
项目 CR组(56例) ICR组(60例) 统计值 P
Bruce分级[级,M(P25,P75)] 3(2,3) 3(2,3) Z=-0.039 0.969
运动时间[s,M(P25,P75)] 607(427,721) 510(390,679) Z=-0.744 0.457
最大METs[M(P25,P75)] 6.3(5.6,7.3) 6.4(5.2,7.4) Z=-0.297 0.767
ST段水平或下斜型下降≥0.1 mV(%) 39.3 38.3 χ2=0.011 0.916
提前中止TET(%) 30.4 31.7 χ2=0.055 0.973
ST段下降程度[mV,M(P25,P75)] 0.00(0.00,0.18) 0.00(0.00,0.17) Z=-0.343 0.731
ST段下降持续时间[s,M(P25,P75)] 0(0,269) 0(0,452) Z=-0.346 0.730
ST段下降形态 ? ? χ2=1.744 0.783
? 上斜型ST段下降(%) 14.2 13.4 ? ?
? 水平型ST段下降(%) 25.0 20.0 ? ?
? 下斜型ST段下降(%) 17.8 26.6 ? ?
最早出现ST段下降的Bruce分级[级,M(P25,P75)] 2(1,2) 1(1,2) Z=-0.475 0.617
胸痛(%) 39.3 46.7 χ2=2.678 0.613
Duke评分[分,M(P25,P75)] 8.07(0.61,12.09) 7.33(-1.16,10.85) Z=-0.690 0.490
Duke评分分级(%) ? ? χ2=1.242 0.537
? 低危 62.5 60.0 ? ?
? 中危 34.4 30.0 ? ?
? 高危 3.1 10.0 ? ?
静息心率(次/min,±s 70±10 73±12 t=-1.473 0.143
静息收缩压(mmHg,±s 120±18 123±18 t=-0.927 0.356
静息舒张压(mmHg,±s 76±11 77±11 t=-0.578 0.565
峰值心率(次/min,±s 129±18 128±18 t=0.464 0.644
峰值收缩压(mmHg,±s 158±20 159±25 t=-0.226 0.822
峰值舒张压(mmHg,±s 83±14 81±14 t=-0.755 0.452
1
Hannan EL, Wu C, Walford G, et al. Incomplete revascularization in the era of drug-eluting stents: impact on adverse outcomes [J]. JACC Cardiovasc Interv, 2009, 2(1): 17-25.
2
Balady GJ, Arena R, Sietsema K, et al. Clinician′s Guide to cardiopulmonary exercise testing in adults: a scientific statement from the American Heart Association [J]. Circulation, 2010, 122(2): 191-225.
3
Sharma K, Kohli P, Gulati M. An update on exercise stress testing [J]. Curr Probl Cardiol, 2012, 37(5): 177-202.
4
Gensini GG. A more meaningful scoring system for determining the severity of coronary heart disease [J]. Am J Cardiol, 1983, 51(3): 606.
5
Hambraeus K, Jensevik K, Lagerqvist B, et al. Long-term outcome of incomplete revascularization after percutaneous coronary intervention in SCAAR (Swedish Coronary Angiography and Angioplasty Registry) [J]. JACC Cardiovasc Interv, 2016, 9(3): 207-215.
6
Engstrøm T, Kelbæk H, Helqvist S, et al. Complete revascularisation versus treatment of the culprit lesion only in patients with ST-segment elevation myocardial infarction and multivessel disease (DANAMI-3—PRIMULTI): an open-label, randomised controlled trial [J]. Lancet, 2015, 386(9994): 665-671.
7
Kim YH, Park DW, Lee JY, et al. Impact of angiographic complete revascularization after drug-eluting stent implantation or coronary artery bypass graft surgery for multivessel coronary artery disease [J]. Circulation, 2011, 123(21): 2373-2381.
8
McLellan CS, Ghali WA, Labinaz M, et al. Association between completeness of percutaneous coronary revascularization and postprocedure outcomes [J]. Am Heart J, 2005, 150(4): 800-806.
9
Garcia S, Sandoval Y, Roukoz H, et al. Outcomes after complete versus incomplete revascularization of patients with multivessel coronary artery disease: a meta-analysis of 89,883 patients enrolled in randomized clinical trials and observational studies [J]. J Am Coll Cardiol, 2013, 62(16): 1421-1431.
10
中华医学会心血管病学分会,中国康复医学会心血管病专业委员会,中国老年学学会心脑血管病专业委员会. 冠心病康复与二级预防中国专家共识 [J]. 中华心血管病杂志, 2013, 41(4): 267-275.
[1] 孔敬博, 耿青, 张玉强. DCG联合TET检查在早期复极综合征合并冠心病诊断中的应用[J]. 中华心脏与心律电子杂志, 2018, 06(02): 80-82.
[2] 王岚, 郭丹杰, 牛亚芊芊, 薛琳, 张天宏, 韩春颖. 平板运动试验假阳性的影响因素及临床价值[J]. 中华心脏与心律电子杂志, 2017, 05(01): 31-34.
阅读次数
全文


摘要